CClinicalTrials.gg
CompletedNCT01137461Updated Apr 14, 2011

Efficacy of Embryo Transfer Procedure Guided by Transvaginal Ultrasound Versus Abdominal Ultrasound in Oocytes Recipients

A Phase 4 interventional study of ultrasound-guided embryo transfer in Infertility, sponsored by Fundació Privada Eugin. Completed at 1 site in Spain. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-04-14.

Sponsored by Fundació Privada Eugin · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
330
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

The objective of this study is to evaluate the efficacy of embryo transfer procedure guided by transvaginal ultrasound versus abdominal ultrasound in recipients of oocytes as well as the advantages and disadvantages of the new technique.

02

Conditions studied

  • Infertility

Browse trials for

Keywords

  • Female infertility with indication of oocyte reception
03

In context

Infertility

2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.

This study's enrollment of 330 is above the median of 120 across 1,698 interventional studies indexed under Infertility.

Browse Infertility studies →

Lead sponsor

Fundació Privada Eugin is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Oocyte recipients.
  • Uterus without previously detected anomalies.
  • Patients able to understand the study requirements who want to participate during all its duration and that have signed the informed consent.

Exclusion criteria

Exclusion Criteria:

  • Turner syndrome, Black race (significantly lower implantational rates)
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
330 participants (actual)

Study arms

  • Other
    abdominal ultrasound

    traditional technique

    Procedure: ultrasound-guided embryo transfer

  • Other
    transvaginal ultrasound

    new technique

    Procedure: ultrasound-guided embryo transfer

Interventions

  • Procedureultrasound-guided embryo transfer

    Embryo transfer in oocyte recipients

06

What researchers measure

Primary outcomes

  1. Clinical pregnancy rate

    Evidence of gestational sac by transvaginal ultrasound

    Time frame: 40 days after embryo transfer

07

Study locations

1 site
  • Clinica EUGIN
    Barcelona, 08029, Spain
08

References and documents

Publications

  • Bodri D, Colodron M, Garcia D, Obradors A, Vernaeve V, Coll O. Transvaginal versus transabdominal ultrasound guidance for embryo transfer in donor oocyte recipients: a randomized clinical trial. Fertil Steril. 2011 Jun;95(7):2263-8, 2268.e1. doi: 10.1016/j.fertnstert.2011.03.028. Epub 2011 Apr 2. PubMed 21459374 ↗

Related links

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 14, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01137461
Lead sponsor
Fundació Privada Eugin
First posted
Jun 4, 2010
Start date
Jun 2010
Primary completion
Oct 2010
Completion
Oct 2010
Last update
Apr 14, 2011

Study contacts

Daniel Bodri
principal investigator · Clinica EUGIN

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion